Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

350 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice.
Cheng D, Low JK, Logge W, Garner B, Karl T. Cheng D, et al. Among authors: karl t. Psychopharmacology (Berl). 2014 Aug;231(15):3009-17. doi: 10.1007/s00213-014-3478-5. Epub 2014 Mar 1. Psychopharmacology (Berl). 2014. PMID: 24577515
Effect of Y1 receptor deficiency on motor activity, exploration, and anxiety.
Karl T, Burne TH, Herzog H. Karl T, et al. Behav Brain Res. 2006 Feb 15;167(1):87-93. doi: 10.1016/j.bbr.2005.08.019. Epub 2005 Oct 3. Behav Brain Res. 2006. PMID: 16203045
Behavioural effects of chronic haloperidol and risperidone treatment in rats.
Karl T, Duffy L, O'brien E, Matsumoto I, Dedova I. Karl T, et al. Behav Brain Res. 2006 Aug 10;171(2):286-94. doi: 10.1016/j.bbr.2006.04.004. Epub 2006 May 11. Behav Brain Res. 2006. PMID: 16697060
Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia.
Karl T, Duffy L, Scimone A, Harvey RP, Schofield PR. Karl T, et al. Genes Brain Behav. 2007 Oct;6(7):677-87. doi: 10.1111/j.1601-183X.2006.00298.x. Epub 2007 Feb 13. Genes Brain Behav. 2007. PMID: 17309661
Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol.
Boucher AA, Arnold JC, Duffy L, Schofield PR, Micheau J, Karl T. Boucher AA, et al. Among authors: karl t. Psychopharmacology (Berl). 2007 Jun;192(3):325-36. doi: 10.1007/s00213-007-0721-3. Epub 2007 Feb 28. Psychopharmacology (Berl). 2007. PMID: 17333138
Heterozygous neuregulin 1 mice display greater baseline and Delta(9)-tetrahydrocannabinol-induced c-Fos expression.
Boucher AA, Hunt GE, Karl T, Micheau J, McGregor IS, Arnold JC. Boucher AA, et al. Among authors: karl t. Neuroscience. 2007 Nov 23;149(4):861-70. doi: 10.1016/j.neuroscience.2007.08.020. Epub 2007 Aug 28. Neuroscience. 2007. PMID: 17905522
Behavioural profile of a new mouse model for NPY deficiency.
Karl T, Duffy L, Herzog H. Karl T, et al. Eur J Neurosci. 2008 Jul;28(1):173-80. doi: 10.1111/j.1460-9568.2008.06306.x. Eur J Neurosci. 2008. PMID: 18616565
Behavioral profile of a heterozygous mutant mouse model for EGF-like domain neuregulin 1.
Duffy L, Cappas E, Scimone A, Schofield PR, Karl T. Duffy L, et al. Among authors: karl t. Behav Neurosci. 2008 Aug;122(4):748-59. doi: 10.1037/0735-7044.122.4.748. Behav Neurosci. 2008. PMID: 18729627
A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
Long LE, Chesworth R, Huang XF, McGregor IS, Arnold JC, Karl T. Long LE, et al. Among authors: karl t. Int J Neuropsychopharmacol. 2010 Aug;13(7):861-76. doi: 10.1017/S1461145709990605. Epub 2009 Sep 29. Int J Neuropsychopharmacol. 2010. PMID: 19785914
Schizophrenia-relevant behaviours in a genetic mouse model for Y2 deficiency.
Karl T, Chesworth R, Duffy L, Herzog H. Karl T, et al. Behav Brain Res. 2010 Mar 5;207(2):434-40. doi: 10.1016/j.bbr.2009.10.029. Epub 2009 Oct 30. Behav Brain Res. 2010. PMID: 19879900
350 results
Jump to page
Feedback